Skip to main content
logo
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.620
+0.050 (3.18%)
Oct 28, 2026, 4:00 PM EDT - Market closed

Inhibikase Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-60.64-48.26-27.52-19.03-18.05-14.79
Depreciation & Amortization
0.020.060.030.180.01-
Asset Writedown & Restructuring Costs
-7.36----
Stock-Based Compensation
19.9615.318.140.50.461.53
Other Operating Activities
-3.13-2.31-0.030.070.72
Change in Accounts Receivable
---0.040.07-0.11
Change in Accounts Payable
-1.640.150.27-0.50.06-0.63
Change in Unearned Revenue
------2.33
Change in Other Net Operating Assets
2.81-0.09-0.070.70.041.3
Operating Cash Flow
-42.61-27.79-19.15-18.09-17.35-14.3
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.01--0.01-0.24-
Sale (Purchase) of Intangibles
--0.44----
Investment in Securities
-115.242.51-3711.67-15.76-
Investing Cash Flow
-115.242.05-3711.66-16.01-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----0.25-0.04
Total Debt Repaid
-----0.25-0.04
Net Debt Issued (Repaid)
-----0.25-0.04
Issuance of Common Stock
111.33108.46103.488.540.0441.21
Repurchase of Common Stock
------0.08
Other Financing Activities
-0.01---0.14--
Financing Cash Flow
111.31108.46103.488.41-0.241.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-46.5482.7347.331.98-33.5626.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-42.61-27.8-19.15-18.1-17.59-14.3
Free Cash Flow Growth
------
Free Cash Flow Margin
----6947.87%-14253.37%-461.10%
Free Cash Flow Per Share
-0.30-0.28-0.81-3.00-4.17-4.71
Levered Free Cash Flow
-22.1-9.56-8.93-12.17-10.97-9.47
Unlevered Free Cash Flow
-22.1-9.56-8.93-12.17-10.97-9.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----00
Change in Working Capital
1.170.060.20.230.17-1.76
SEC Filings: 10-K · 10-Q